Publication Name	World Journal of Dermatology
Manuscript ID	33543
Country	United Kingdom

Received	2017-02-15 08:55
Peer-Review Started	2017-02-15 19:07
To Make the First Decision	2017-03-06 17:49
Return for Revision	2017-03-07 14:23
Revised	2017-03-14 05:57
Second Decision	2017-03-24 11:30
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2017-04-07 15:32
Articles in Press	2017-04-07 15:32
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-07-18 08:35
Publish the Manuscript Online	2017-07-24 04:29

ISSN	2218-6190 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Dermatology
Manuscript Type	Minireviews
Article Title	Atopic eczema treatment now and in the future: Targeting the skin barrier and key immune mechanisms in human skin
Manuscript Source	Unsolicited Manuscript
All Author List	David C Bell and Sara J Brown
Funding Agency and Grant Number
Corresponding Author	Sara J Brown, Professor of Molecular and Genetic Dermatology, Wellcome Trust Senior Research Fellow in Clinical Science, Honorary Consultant Dermatologist, Skin Research Group, School of Medicine, Ninewells Hospital and Medical School, University of Dundee, James Arrott Drive, Dundee DD1 9SY, Scotland, United Kingdom. s.j.brown@dundee.ac.uk
Key Words	Atopic eczema; Novel treatment; Filaggrin; Skin barrier; Immune dysfunction
Core Tip	Atopic eczema (atopic dermatitis) is an itchy inflammatory skin disease with complex aetiology, including impairment in barrier function and concomitant inflammation. Increased understanding of the molecular mechanisms in eczema pathogenesis has opened up opportunities for new therapeutic targets. This review summaries current understanding and highlights some novel treatments in development.
Publish Date	2017-07-24 04:29
Citation	Bell DC, Brown SJ. Atopic eczema treatment now and in the future: Targeting the skin barrier and key immune mechanisms in human skin. World J Dermatol 2017; 6(3): 42-51
URL	http://www.wjgnet.com/2218-6190/full/v6/i3/42.htm
DOI	http://dx.doi.org/10.5314/wjd.v6.i3.42

Full Article (PDF)	WJD-6-42.pdf
Full Article (Word)	WJD-6-42.doc
Manuscript File	33543-Review.docx
Answering Reviewers	33543-Answering reviewers.pdf
Audio Core Tip	33543-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	33543-Conflict-of-interest statement.pdf
Copyright License Agreement	33543-Copyright assignment.pdf
Peer-review Report	33543-Peer-review(s).pdf
Scientific Misconduct Check	33543-Scientific misconduct check.pdf
Scientific Editor Work List	33543-Scientific editor work list.pdf